Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 5:10 PM View:  | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 03-Apr-24 | Sale (Planned) | 2,214 | $2.78 | $6,143.85 | (11%) 19.37K to 17.15K | |
| 03-Apr-24 5:09 PM View: | Schuchart Aaron Chief Business Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 1,000 | $2.84 | $2,840.00 | 18% 5.68K to 6.68K | |
| 03-Apr-24 5:10 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Payment of Exercise | 1,522 | $2.84 | $4,322.48 | (< 1%) 759.08K to 757.56K | |
| 03-Apr-24 5:11 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Payment of Exercise | 274 | $2.84 | $778.16 | (2%) 12.79K to 12.51K | |
| 03-Apr-24 5:10 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Payment of Exercise | 1,036 | $2.84 | $2,942.24 | (5%) 20.4K to 19.37K | |
| 03-Apr-24 5:11 PM View: | Powers Bradley J General Counsel | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 900 | $2.84 | $2,556.00 | 16% 5.78K to 6.68K | |
| 03-Apr-24 5:10 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 4,500 | $2.84 | $12,780.00 | < 1% 754.58K to 759.08K | |
| 03-Apr-24 5:11 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 1,000 | $2.84 | $2,840.00 | 8% 11.79K to 12.79K | |
| 03-Apr-24 5:10 PM View: | Pitukcheewanont Pisit Duke Chief Medical Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 6,000 | $2.84 | $17,040.00 | 55% 10.93K to 16.93K | |
| 03-Apr-24 5:10 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 2,000 | $2.84 | $5,680.00 | 11% 18.4K to 20.4K | |
| 03-Apr-24 5:11 PM View: | Powers Bradley J General Counsel | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Payment of Exercise | 342 | $2.84 | $971.28 | (5%) 6.68K to 6.33K | |
| 07-Feb-24 5:22 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 06-Feb-24 | Sale (Planned) | 438 | $3.03 | $1,328.02 | (2%) 18.84K to 18.4K | |
| 05-Feb-24 5:55 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 366 | $3.01 | $1,101.66 | (2%) 19.21K to 18.84K | |
| 05-Feb-24 5:51 PM View: | Powers Bradley J General Counsel | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 240 | $3.01 | $722.40 | (4%) 6.02K to 5.78K | |
| 05-Feb-24 5:54 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 690 | $3.01 | $2,076.90 | (< 1%) 755.27K to 754.58K | |
| 05-Feb-24 5:53 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 215 | $3.01 | $647.15 | (2%) 12.0K to 11.79K | |
| 05-Feb-24 5:52 PM View: | Schuchart Aaron Chief Business Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 202 | $3.01 | $608.02 | (3%) 5.88K to 5.68K | |
| 03-Aug-23 4:58 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 02-Aug-23 | Sale (Planned) | 3,407 | $3.20 | $10,919.40 | (15%) 22.11K to 18.71K | |
| 03-Aug-23 4:58 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Aug-23 | Payment of Exercise | 229 | $3.28 | $751.12 | (2%) 11.73K to 11.5K | |
| 03-Aug-23 4:58 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Aug-23 | Payment of Exercise | 1,593 | $3.28 | $5,225.04 | (7%) 23.71K to 22.11K | |
| 04-Apr-23 5:22 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 04-Apr-23 | Sale (Planned) | 2,214 | $3.27 | $7,239.78 | (9%) 25.42K to 23.21K | |
| 04-Apr-23 5:21 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 01-Apr-23 | Payment of Exercise | 1,522 | $3.31 | $5,037.82 | (< 1%) 756.8K to 755.27K | |
| 04-Apr-23 5:21 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-23 | Payment of Exercise | 274 | $3.31 | $906.94 | (2%) 11.51K to 11.23K | |
| 04-Apr-23 5:22 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Apr-23 | Payment of Exercise | 1,036 | $3.31 | $3,429.16 | (4%) 26.46K to 25.42K | |
| 04-Apr-23 5:22 PM View: | Powers Bradley J General Counsel | Lumos Pharma, Inc. (LUMO) | 01-Apr-23 | Payment of Exercise | 342 | $3.31 | $1,132.02 | (5%) 6.36K to 6.02K | |
| 03-Feb-23 5:03 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 02-Feb-23 | Sale (Planned) | 439 | $3.53 | $1,549.67 | (2%) 26.9K to 26.46K | |
| 03-Feb-23 5:02 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 4,500 | $3.52 | $15,840.00 | < 1% 752.71K to 757.21K | |
| 03-Feb-23 5:04 PM View: | Schuchart Aaron Chief Business Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 1,000 | $3.52 | $3,520.00 | 22% 4.49K to 5.49K | |
| 03-Feb-23 5:04 PM View: | Powers Bradley J General Counsel | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 900 | $3.52 | $3,168.00 | 16% 5.59K to 6.49K | |
| 03-Feb-23 5:02 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 416 | $3.52 | $1,464.32 | (< 1%) 757.21K to 756.8K | |
| 03-Feb-23 5:04 PM View: | Schuchart Aaron Chief Business Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 104 | $3.52 | $366.08 | (2%) 5.49K to 5.38K | |
| 03-Feb-23 5:03 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 114 | $3.52 | $401.28 | (< 1%) 11.62K to 11.51K | |
| 03-Feb-23 5:03 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 206 | $3.52 | $725.12 | (< 1%) 27.1K to 26.9K | |
| 03-Feb-23 5:02 PM View: | Karpf David B Chief Medical Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 36 | $3.52 | $126.72 | (< 1%) 8.33K to 8.29K | |
| 03-Feb-23 5:04 PM View: | Powers Bradley J General Counsel | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 131 | $3.52 | $461.12 | (2%) 6.49K to 6.36K | |
| 03-Feb-23 5:03 PM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 1,000 | $3.52 | $3,520.00 | 9% 10.62K to 11.62K | |
| 03-Feb-23 5:03 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 2,000 | $3.52 | $7,040.00 | 8% 25.1K to 27.1K | |
| 03-Feb-23 5:02 PM View: | Karpf David B Chief Medical Officer | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 1,000 | $3.52 | $3,520.00 | 14% 7.33K to 8.33K | |
| 18-Nov-22 4:31 PM View: | McCracken Joseph S Director | Lumos Pharma, Inc. (LUMO) | 16-Nov-22 | Private Purchase | 4,000 | $5.03 | $20,120.00 | 34% 11.72K to 15.72K | |
| 23-Sep-22 5:05 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 23-Sep-22 | Purchase | 208 | $8.80 | $1,830.40 | < 1% 752.5K to 752.71K | |
| 23-Sep-22 5:05 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 21-Sep-22 | Purchase | 2,214 | $8.84 | $19,571.80 | < 1% 750.29K to 752.5K | |
| 21-Sep-22 6:45 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 20-Sep-22 | Purchase | 1,506 | $8.75 | $13,177.50 | < 1% 748.78K to 750.29K | |
| 21-Sep-22 6:45 PM View: | Hawkins Richard J Chief Executive Officer Director | Lumos Pharma, Inc. (LUMO) | 19-Sep-22 | Purchase | 541 | $8.65 | $4,679.65 | < 1% 748.24K to 748.78K | |
| 06-Sep-22 4:55 PM View: | Karpf David B Chief Medical Officer | Lumos Pharma, Inc. (LUMO) | 01-Sep-22 | Payment of Exercise | 570 | $8.53 | $4,862.10 | (7%) 7.9K to 7.33K | |
| 26-Aug-22 4:59 PM View: | McCracken Joseph S Director | Lumos Pharma, Inc. (LUMO) | 25-Aug-22 | Purchase | 3,170 | $8.60 | $27,262.00 | 37% 8.55K to 11.72K | |
| 26-Aug-22 5:00 PM View: | Raffin Thomas A. Director | Lumos Pharma, Inc. (LUMO) | 25-Aug-22 | Purchase | 1,150 | $8.46 | $9,729.00 | 14% 8.26K to 9.41K | |
| 03-Aug-22 11:25 AM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 02-Aug-22 | Sale (Planned) | 3,407 | $8.11 | $27,630.80 | (12%) 28.01K to 24.6K | |
| 03-Aug-22 11:25 AM View: | Lawley Lori D Chief Financial Officer | Lumos Pharma, Inc. (LUMO) | 01-Aug-22 | Payment of Exercise | 229 | $8.17 | $1,870.93 | (2%) 10.35K to 10.12K | |
| 03-Aug-22 11:25 AM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 01-Aug-22 | Payment of Exercise | 1,593 | $8.17 | $13,014.80 | (5%) 29.6K to 28.01K | |
| 07-Jun-22 4:23 PM View: | McKew John C. Chief Scientific Officer | Lumos Pharma, Inc. (LUMO) | 06-Jun-22 | Private Sale (Planned) | 169 | $7.62 | $1,287.78 | (< 1%) 29.27K to 29.1K |
